Tcr2 Therapeutics Inc.

Bank of New York Mellon Corp

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/9/2023

Shares

12,755

Value ($000)

19

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/9/2023	19	0.0%	12,755	3/31/2023
2022 Q4	2/14/2023	13	0.0%	12,755	12/31/2022
2022 Q3	11/14/2022	23	0.0%	12,755	9/30/2022
2022 Q2	8/15/2022	37	0.0%	12,755	6/30/2022
2022 Q1	5/11/2022	285	0.0%	103,470	3/31/2022
2021 Q4	2/11/2022	519	0.0%	111,363	12/31/2021
2021 Q3	11/18/2021	913	0.0%	107,342	9/30/2021
2021 Q2	8/11/2021	1,902	0.0%	115,892	6/30/2021
2021 Q1	5/13/2021	2,762	0.0%	125,080	3/31/2021
2020 Q4	2/9/2021	3,877	0.0%	125,365	12/31/2020
2020 Q3	11/12/2020	1,579	0.0%	77,676	9/30/2020
2020 Q2	8/12/2020	839	0.0%	54,590	6/30/2020
2020 Q1	5/6/2020	321	0.0%	41,475	3/31/2020
2019 Q4	2/14/2020	592	0.0%	41,475	12/31/2019